首页> 外文期刊>Molecular biology of the cell >DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptors
【24h】

DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptors

机译:DHHC-7和-21是性甾体受体的棕榈糖基转移酶

获取原文
获取原文并翻译 | 示例
           

摘要

Classical estrogen, progesterone, and androgen receptors (ERs, PRs, and ARs) localize outside the nucleus at the plasma membrane of target cells. From the membrane, the receptors signal to activate kinase cascades that are essential for the modulation of transcription and nongenomic functions in many target cells. ER, PR, and AR trafficking to the membrane requires receptor palmitoylation by palmitoylacyltransferase (PAT) protein(s). However, the identity of the steroid receptor PAT(s) is unknown. We identified the DHHC-7 and -21 proteins as conserved PATs for the sex steroid receptors. From DHHC-7 and -21 knockdown studies, the PATs are required for endogenous ER, PR, and AR palmitoylation, membrane trafficking, and rapid signal transduction in cancer cells. Thus the DHHC-7 and -21 proteins are novel targets to selectively inhibit membrane sex steroid receptor localization and function.
机译:经典的雌激素,孕激素和雄激素受体(ER,PR和AR)位于靶细胞质膜的细胞核外。受体从膜发出信号以激活激酶级联反应,这对于调节许多靶细胞中的转录和非基因组功能至关重要。 ER,PR和AR向膜的运输需要通过棕榈酰糖基转移酶(PAT)蛋白将受体棕榈酰化。但是,类固醇受体PAT的身份未知。我们确定DHHC-7和-21蛋白为性类固醇受体的保守PAT。根据DHHC-7和-21敲低研究,PAT是癌细胞内源性ER,PR和AR棕榈酰化,膜运输和快速信号转导所必需的。因此,DHHC-7和-21蛋白是选择性抑制膜性类固醇受体定位和功能的新型靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号